La liste des publications est mise à jour tous les jours via PubMed et seules les publications les plus récentes sont affichées sur cette page. Une liste incluant seulement les articles de revue scientifique, Publications récentes (revues), est également disponible. Les cheurcheurs IDIGH sont en gras. 

CBT

  1. Xu, F., Wang, G., Zhao, F., Huang, Y., Fan, Z., Mei, S., Xie, Y., Wei, L., Hu, Y., Wang, C., Cen, S., Liang, C., Ren, L., Guo, F. & Wang, J. (2022). IFITM3 Inhibits SARS-CoV-2 Infection and Is Associated with COVID-19 Susceptibility. Viruses, vol. 14.
  2. Paulini, K., Lypaczewski, P., Zhang, W.-W., Perera, D. J., Ndao, M. & Matlashewski, G. (2022). Investigating the Leishmania donovani sacp Gene and Its Role in Macrophage Infection and Survival in Mice. Tropical medicine and infectious disease, vol. 7.
  3. van Griensven, J., Diro, E. & Yansouni, C. P. (2022). Hidden sources of bias in diagnostic studies: the example of visceral leishmaniasis in east Africa. The Lancet. Infectious diseases.
  4. Hua, M., Jiang, T., Cheng, J., Fu, J., Dun, X., Taibo, A., Netchiporouk, E. & Zhang, H. (2022). Treatment of progressive nodular histiocytosis: a case report. Annals of translational medicine, vol. 10, p. 1143.
  5. Costiniuk, C. T. & Ahmad, A. (2022). Potential HIV/ART-mediated germline mutations causing congenital inborn errors of immunity in children born to HIV+ couples: an alarming spectre. AIDS (London, England), vol. 36, p. 2215-2216.
  6. Drummond, R. A., Desai, J. V., Hsu, A. P., Oikonomou, V., Vinh, D. C., Acklin, J. A., Abers, M. S., Walkiewicz, M. A., Anzick, S. L., Swamydas, M., Vautier, S., Natarajan, M., Oler, A. J., Yamanaka, D., Mayer-Barber, K. D., Iwakura, Y., Bianchi, D., Driscoll, B., Hauck, K., Kline, A., Viall, N. S., Zerbe, C. S., Ferré, E. M., Schmitt, M. M., DiMaggio, T., Pittaluga, S., Butman, J. A., Zelazny, A. M., Shea, Y. R., Arias, C. A., Ashbaugh, C., Mahmood, M., Temesgen, Z., Theofiles, A. G., Nigo, M., Moudgal, V., Bloch, K. C., Kelly, S. G., Whitworth, M. S., Rao, G., Whitener, C. J., Mafi, N., Gea-Banacloche, J., Kenyon, L. C., Miller, W. R., Boggian, K., Gilbert, A., Sincock, M., Freeman, A. F., Bennett, J. E., Hasbun, R., Mikelis, C. M., Kwon-Chung, K. J., Belkaid, Y., Brown, G. D., Lim, J. K., Kuhns, D. B., Holland, S. M. & Lionakis, M. S. (2022). Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis. The Journal of clinical investigation, vol. 132.
  7. Butler-Laporte, G., Gonzalez-Kozlova, E., Su, C.-Y., Zhou, S., Nakanishi, T., Brunet-Ratnasingham, E., Morrison, D., Laurent, L., Aflalo, J., Aflalo, M., Henry, D., Chen, Y., Carrasco-Zanini, J., Farjoun, Y., Pietzner, M., Kimchi, N., Afrasiabi, Z., Rezk, N., Bouab, M., Petitjean, L., Guzman, C., Xue, X., Tselios, C., Vulesevic, B., Adeleye, O., Abdullah, T., Almamlouk, N., Moussa, Y., DeLuca, C., Duggan, N., Schurr, E., Brassard, N., Durand, M., Del Valle, D. M., Thompson, R., Cedillo, M. A., Schadt, E., Nie, K., Simons, N. W., Mouskas, K., Zaki, N., Patel, M., Xie, H., Harris, J., Marvin, R., Cheng, E., Tuballes, K., Argueta, K., Scott, I., Mount Sinai COVID-19 Biobank Team, Greenwood, C. M. T., Paterson, C., Hinterberg, M., Langenberg, C., Forgetta, V., Mooser, V., Marron, T., Beckmann, N. D., Kenigsberg, E., Charney, A. W., Kim-Schulze, S., Merad, M., Kaufmann, D. E., Gnjatic, S. & Richards, J. B. (2022). Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals. Clinical proteomics, vol. 19, p. 40.
  8. Gobeil, P., Pillet, S., Boulay, I., Charland, N., Lorin, A., Cheng, M. P., Vinh, D. C., Boutet, P., Van Der Most, R., Roman, F., Ceregido, M. A., Landry, N., D'Aoust, M.-A. & Ward, B. J. (2022). Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19. Nature communications, vol. 13, p. 6905.
  9. Wang, Z., Jenabian, M.-A., Alexandrova, Y., Pagliuzza, A., Olivenstein, R., Samarani, S., Chomont, N., Kembel, S. W. & Costiniuk, C. T. (2022). Interplay between the Lung Microbiome, Pulmonary Immunity and Viral Reservoirs in People Living with HIV under Antiretroviral Therapy. Viruses, vol. 14.
  10. Sebastiani, G., Paisible, N., Costiniuk, C., Cox, J., Kablawi, D., Klein, M. B., Kronfli, N., Routy, J.-P., Falutz, J., Lebouché, B. & Guaraldi, G. (2022). The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot Study. Diagnostics (Basel, Switzerland), vol. 12.
  11. Bergeri, I., Whelan, M. G., Ware, H., Subissi, L., Nardone, A., Lewis, H. C., Li, Z., Ma, X., Valenciano, M., Cheng, B., Al Ariqi, L., Rashidian, A., Okeibunor, J., Azim, T., Wijesinghe, P., Le, L.-V., Vaughan, A., Pebody, R., Vicari, A., Yan, T., Yanes-Lane, M., Cao, C., Clifton, D. A., Cheng, M. P., Papenburg, J., Buckeridge, D., Bobrovitz, N., Arora, R. K., Van Kerkhove, M. D. & Unity Studies Collaborator Group (2022). Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. PLoS medicine, vol. 19, p. e1004107.
  12. Charland, N., Gobeil, P., Pillet, S., Boulay, I., Séguin, A., Makarkov, A., Heizer, G., Bhutada, K., Mahmood, A., Trépanier, S., Hager, K., Jiang-Wright, J., Atkins, J., Saxena, P., Cheng, M. P., Vinh, D. C., Boutet, P., Roman, F., Van Der Most, R., Ceregido, M. A., Dionne, M., Tellier, G., Gauthier, J.-S., Essink, B., Libman, M., Haffizulla, J., Fréchette, A., D'Aoust, M.-A., Landry, N. & Ward, B. J. (2022). Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities. NPJ vaccines, vol. 7, p. 142.
  13. Wardell, J. D., Rueda, S., Fox, N., Costiniuk, C. T., Jenabian, M.-A., Margolese, S., Mandarino, E., Shuper, P., Hendershot, C. S., Cunningham, J. A., Arbess, G. & Singer, J. (2022). Disentangling Medicinal and Recreational cannabis Use Among People Living with HIV: An Ecological Momentary Assessment Study. AIDS and behavior.
  14. Sullivan, J. R., Yao, J., Courtine, C., Lupien, A., Herrmann, J., Müller, R. & Behr, M. A. (2022). Natural Products Lysobactin and Sorangicin A Show In Vitro Activity against Mycobacterium abscessus Complex. Microbiology spectrum, p. e0267222.
  15. Eshraghisamani, R., Mirto, A. J., Wang, J., Behr, M. A., Barkema, H. W. & De Buck, J. (2022). Identification of essential genes in Mycobacterium avium subsp. paratuberculosis genome for persistence in dairy calves. Frontiers in microbiology, vol. 13, p. 994421.
  16. Grant, J. M., Chan, J., Lother, S. A., Barrett, L., Bonnar, P. E., Findlater, A. R., Kassim, S. S., Lam, J. C. & Vinh, D. C. (2022). AMMI Canada Practice Point: Treatments for adults with COVID-19 in 2021-2022. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 163-169.
  17. Mendel, A., Colmegna, I., Bourque, G., Rajda, E., Lee, T. C., Gálvez, J. H., Vinet, É. & Cheng, M. P. (2022). More than a 'Hundred Days War': Persistent SARS-CoV-2 infection in a patient with ANCA-associated vasculitis. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 131-134.
  18. Lafleur, A. & Olivier, M. (2022). Viral endosymbiotic infection of protozoan parasites: How it influences the development of cutaneous leishmaniasis. PLoS pathogens, vol. 18, p. e1010910.
  19. Nantel, S., Bourdin, B., Adams, K., Carbonneau, J., Rabezanahary, H., Hamelin, M.-È., McCormack, D., Savard, P., Longtin, Y., Cheng, M. P., De Serres, G., Corbeil, J., Gilca, V., Baz, M., Boivin, G., Quach, C. & Decaluwe, H. (2022). Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine. Frontiers in immunology, vol. 13, p. 930252.
  20. Ortiz-Brizuela, E., Menzies, D. & Behr, M. A. (2022). Testing and Treating Mycobacterium tuberculosis Infection. The Medical clinics of North America, vol. 106, p. 929-947.
  21. Colmegna, I. & Weinblatt, M. E. (2022). From Canadian Living Guidelines to Global Living Guidelines: A Post Pandemic Effort. The Journal of rheumatology, vol. 49, p. 1077-1078.
  22. Bellini, N., Lodge, R., Pham, T. N. Q., Jain, J., Murooka, T. T., Herschhorn, A., Bernard, N. F., Routy, J.-P., Tremblay, C. L. & Cohen, É. A. (2022). MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4+ T cells. iScience, vol. 25, p. 105234.
  23. Liu, S., Le Mauff, F., Sheppard, D. C. & Zhang, S. (2022). Filamentous fungal biofilms: Conserved and unique aspects of extracellular matrix composition, mechanisms of drug resistance and regulatory networks in Aspergillus fumigatus. NPJ biofilms and microbiomes, vol. 8, p. 83.
  24. Chambers, C., Samji, H., Cooper, C. L., Costiniuk, C. T., Janjua, N. Z., Kroch, A. E., Arbess, G., Benoit, A. C., Buchan, S. A., Chung, H., Kendall, C. E., Kwong, J. C., Langlois, M.-A., Lee, S. M., Mbuagbaw, L., Mccullagh, J., Moineddin, R., Nambiar, D., Walmsley, S., Anis, A., Burchell, A. N. & COVAXHIV Study Team (2022). COVID-19 Vaccine Effectiveness among a Population-based Cohort of People Living with HIV. AIDS (London, England), vol. 36, p. F17-F26.
  25. Siavash Moakhar, R., Del Real Mata, C., Jalali, M., Shafique, H., Sanati, A., de Vries, J., Strauss, J., AbdElFatah, T., Ghasemi, F., McLean, M., I Hosseini, I., Lu, Y., Yedire, S. G., Mahshid, S. S., Tabatabaiefar, M. A., Liang, C. & Mahshid, S. (2022). A Versatile Biomimic Nanotemplating Fluidic Assay for Multiplex Quantitative Monitoring of Viral Respiratory Infections and Immune Responses in Saliva and Blood. Advanced science (Weinheim, Baden-Wurttemberg, Germany), p. e2204246.

 

CRES

  1. Bouabida, K., Lebouché, B. & Pomey, M.-P. (2022). Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic. Healthcare (Basel, Switzerland), vol. 10.
  2. Medeiros, P., Warren, L., Kazemi, M., Massaquoi, N., Smith, S., Tharao, W., Serghides, L., Logie, C. H., Kroch, A., Burchell, A. N., de Pokomandy, A., Kaida, A., Loutfy, M. & CHIWOS Research Team (2022). HIV care cascade for women living with HIV in the Greater Toronto Area versus the rest of Ontario and Canada. International journal of STD & AIDS, p. 9564624221108034.
  3. Pucchio, A., Akiva, M. H., Evangeliou, H., Papenburg, J. & Salvadori, M. I. (2022). Severe rhabdomyolysis secondary to COVID-19 mRNA vaccine in a teenager. Pediatric nephrology (Berlin, Germany).
  4. Ryder, J. H., Tong, S. Y. C., Gallagher, J. C., McDonald, E. G., Thevarajan, I., Lee, T. C. & Cortés-Penfield, N. W. (2022). Deconstructing the Dogma: Systematic Literature Review and Meta-analysis of Adjunctive Gentamicin and Rifampin in Staphylococcal Prosthetic Valve Endocarditis. Open forum infectious diseases, vol. 9, p. ofac583.
  5. Almeida-Brasil, C. C., Hanly, J. G., Urowitz, M., Clarke, A. E., Ruiz-Irastorza, G., Gordon, C., Ramsey-Goldman, R., Petri, M. A., Ginzler, E. M., Wallace, D. J., Bae, S.-C., Romero-Diaz, J., Dooley, M.-A., Peschken, C., Isenberg, D., Rahman, A., Manzi, S., Jacobsen, S., Lim, S. S., van Vollenhoven, R., Nived, O., Jönsen, A., Kamen, D. L., Aranow, C., Sánchez-Guerrero, J., Gladman, D. D., Fortin, P. R., Alarcon, G. S., Merrill, J. T., Kalunian, K., Ramos-Casals, M., Steinsson, K., Zoma, A., Askanase, A. D., Khamashta, M., Bruce, I. N., Inanc, M., Lukusa, L. & Bernatsky, S. (2022). Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine. Lupus science & medicine, vol. 9.
  6. Sebastiani, G., Paisible, N., Costiniuk, C., Cox, J., Kablawi, D., Klein, M. B., Kronfli, N., Routy, J.-P., Falutz, J., Lebouché, B. & Guaraldi, G. (2022). The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot Study. Diagnostics (Basel, Switzerland), vol. 12.
  7. Bergeri, I., Whelan, M. G., Ware, H., Subissi, L., Nardone, A., Lewis, H. C., Li, Z., Ma, X., Valenciano, M., Cheng, B., Al Ariqi, L., Rashidian, A., Okeibunor, J., Azim, T., Wijesinghe, P., Le, L.-V., Vaughan, A., Pebody, R., Vicari, A., Yan, T., Yanes-Lane, M., Cao, C., Clifton, D. A., Cheng, M. P., Papenburg, J., Buckeridge, D., Bobrovitz, N., Arora, R. K., Van Kerkhove, M. D. & Unity Studies Collaborator Group (2022). Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. PLoS medicine, vol. 19, p. e1004107.
  8. Dong, H., Stringfellow, E. J., Russell, W. A. & Jalali, M. S. (2022). Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US. JAMA psychiatry.
  9. Mayo, N. E., Levine, B., Brouillette, M.-J., Bélanger, D. & Fellows, L. K. (2022). Efficacy potential of Goal Management Training to improve cognitive function in older people living with HIV. Contemporary clinical trials communications, vol. 30, p. 101023.
  10. Hordyk, S. R., Macdonald, M. E., Brassard, P., Okalik, L. & Papigatuk, L. (2022). No time to grieve: Inuit loss experiences and grief practices in Nunavik, Quebec. Transcultural psychiatry, p. 13634615221135423.
  11. Aoki, F. Y., Papenburg, J., Mubareka, S., Allen, U. D., Hatchette, T. F. & Evans, G. A. (2022). 2021-2022 AMMI Canada guidance on the use of antiviral drugs for influenza in the COVID-19 pandemic setting in Canada. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 1-7.
  12. Schwartz, I. S., Lee, T. C., McDonald, E. G. & Laupland, K. B. (2021). What went wrong: A reckoning of Canada's contributions to evidence-based medicine through clinical trials during the COVID-19 pandemic. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 6, p. 241-244.
  13. Cvetkovic, A., King, E., Skerritt, L., Loutfy, M., Tseng, A., Murray, M., van Schalkwyk, J., Boucoiran, I., Marcotte, S., Hankins, C., Savoie, É., de Pokomandy, A., Pick, N., Tkachuk, S., Rowe, T., Smaill, F. & Walmsley, S. (2021). A practical clinical guide to counselling on and managing contraception, pre-conception planning, and menopause for women living with HIV. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 6, p. 278-295.
  14. Nicolau, I. A., Shokoohi, M., McBane, J. E., Pogany, L., Popovic, N., Nicholson, V., Hillier, S., Aran, N., Brophy, J., Burt, K., Cox, J., de Pokomandy, A., Kakkar, F., Kelly, D., Kerkerian, G., Kogilwaimath, S., Kroch, A., Dias Lima, V., Linthwaite, B., Mbuagbaw, L., McClarty, L., Turvey, S., Owino, M., Martin, C., Hogg, R. S. & Loutfy, M. (2022). A two-day workshop reviewing Canadian provincial and national HIV care cascade indicators, reporting, challenges, and recommendations. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 247-268.
  15. Mendel, A., Colmegna, I., Bourque, G., Rajda, E., Lee, T. C., Gálvez, J. H., Vinet, É. & Cheng, M. P. (2022). More than a 'Hundred Days War': Persistent SARS-CoV-2 infection in a patient with ANCA-associated vasculitis. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 131-134.
  16. Daroya, E., Grey, C., Lessard, D., Klassen, B., Skakoon-Sparling, S., Gaspar, M., Perez-Brumer, A., Adam, B., Lachowsky, N. J., Moore, D., Sang, J. M., Lambert, G., Hart, T. A., Cox, J., Jollimore, J., Tan, D. H. S. & Grace, D. (2022). 'I did not have sex outside of our bubble': changes in sexual practices and risk reduction strategies among sexual minority men in Canada during the COVID-19 pandemic. Culture, health & sexuality, p. 1-17.
  17. Liu, J. L., Woo, J. M. P., Parks, C. G., Costenbader, K. H., Jacobsen, S. & Bernatsky, S. (2022). Systemic Lupus Erythematosus Risk: The Role of Environmental Factors. Rheumatic diseases clinics of North America, vol. 48, p. 827-843.
  18. Alanaeme, C. J., Sarvesh, S., Li, C. Y., Bernatsky, S., Curtis, J. R. & Yun, H. (2022). Adherence patterns in naïve and prevalent use of infliximab and its biosimilar. BMC rheumatology, vol. 6, p. 65.
  19. Copaescu, A. M., Ben-Shoshan, M. & Trubiano, J. A. (2022). Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions. Frontiers in medicine, vol. 9, p. 923991.
  20. Quan, J., Ma, C., Panaccione, R., Hracs, L., Sharifi, N., Herauf, M., Markovinović, A., Coward, S., Windsor, J. W., Caplan, L., Ingram, R. J. M., Charlton, C., Kanji, J. N., Tipples, G., Holodinsky, J. K., Bernstein, C. N., Mahoney, D. J., Bernatsky, S., Benchimol, E. I., Kaplan, G. G. & STOP COVID-19 in IBD Research Group (2022). Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease. The lancet. Gastroenterology & hepatology, vol. 7, p. 1077-1079.
  21. Sang, J. M., McAllister, K., Wang, L., Barath, J., Lal, A., Parlette, A., Noor, S. W., Apelian, H., Skakoon-Sparling, S., Hull, M., Moore, D. M., Cox, J., Hart, T. A., Lambert, G., Grace, D., Jollimore, J., Hogg, R. S. & Lachowsky, N. J. (2022). Examining provincial PrEP coverage and characterizing PrEP awareness and use among gay, bisexual and other men who have sex with men in Vancouver, Toronto and Montreal, 2017-2020. Journal of the International AIDS Society, vol. 25, p. e26017.
  22. Sekhon, H., Lavin, P., Vacaflor, B., Rigas, C., Cinalioglu, K., Su, C.-L., Bodenstein, K., Dikaios, E., Goodman, A., Raymond, F. C., Ibrahim, M., Bein, M., Gruber, J., Se, J., Sasi, N., Walsh, C., Nazar, R., Hanganu, C., Berkani, S., Royal, I., Schiavetto, A., Looper, K., Launay, C., McDonald, E. G., Seitz, D., Kumar, S., Beauchet, O., Khoury, B., Bouchard, S., Battistini, B., Fallavollita, P., Miresco, M., Bruneau, M.-A., Vahia, I., Bukhari, S. & Rej, S. (2022). Isolating together during COVID-19: Results from the Telehealth Intervention Program for older adults. Frontiers in medicine, vol. 9, p. 948506.
  23. Cardwell, F. S., Elliott, S. J., Chin, R., St Pierre, Y., Choi, M. Y., Urowitz, M. B., Ruiz-Irastorza, G., Bernatsky, S., Wallace, D. J., Petri, M. A., Manzi, S., Bae, S.-C., Shin, J.-M., Mak, A., Cho, J., Peschken, C. A., Ramsey-Goldman, R., Fortin, P. R., Hanly, J. G., Pons-Estel, B. A., Nieto, R., Askanase, A. D., Romero-Diaz, J., Mosca, M., Bruce, I. N., Rowbottom, L., Mielczarek, L., Tse, K., Marion, A., Cáhiz-González, J. C., Cattoni, T. G., Cornet, A. & Clarke, A. E. (2022). Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic. Lupus science & medicine, vol. 9.
  24. Romanchuk, K., Linthwaite, B., Cox, J., Park, H., Dussault, C., Basta, N. E., Varsaneux, O., Worthington, J., Lebouché, B., MacDonald, S. E., Ismail, S. J. & Kronfli, N. (2022). Determinants of SARS-CoV-2 vaccine willingness among people incarcerated in 3 Canadian federal prisons: a cross-sectional study. CMAJ open, vol. 10, p. E922-E929.
  25. Linthwaite, B., Kronfli, N., Lessard, D., Engler, K., Ruppenthal, L., Bourbonnière, E., Obas, N., Brown, M., Lebouché, B., Cox, J. & CVIS clinical team (2022). Implementation of Lost & Found, An Intervention to Reengage Patients Out of HIV Care: A Convergent Explanatory Sequential Mixed-Methods Analysis. AIDS and behavior.

 

Clinique

  1. Ryder, J. H., Tong, S. Y. C., Gallagher, J. C., McDonald, E. G., Thevarajan, I., Lee, T. C. & Cortés-Penfield, N. W. (2022). Deconstructing the Dogma: Systematic Literature Review and Meta-analysis of Adjunctive Gentamicin and Rifampin in Staphylococcal Prosthetic Valve Endocarditis. Open forum infectious diseases, vol. 9, p. ofac583.
  2. De Marco, D., Bessissow, T., Marcus, V. & Benmassaoud, A. (2022). Vedolizumab-Associated Hypereosinophilia and Hepatoxicity. ACG case reports journal, vol. 9, p. e00905.
  3. Lee, T. C., Pogue, J. M., McCreary, E. K. & Morris, A. M. (2022). What is the place in therapy for nirmatrelvir/ritonavir?. BMJ evidence-based medicine.
  4. Sebastiani, G., Paisible, N., Costiniuk, C., Cox, J., Kablawi, D., Klein, M. B., Kronfli, N., Routy, J.-P., Falutz, J., Lebouché, B. & Guaraldi, G. (2022). The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot Study. Diagnostics (Basel, Switzerland), vol. 12.
  5. Charland, N., Gobeil, P., Pillet, S., Boulay, I., Séguin, A., Makarkov, A., Heizer, G., Bhutada, K., Mahmood, A., Trépanier, S., Hager, K., Jiang-Wright, J., Atkins, J., Saxena, P., Cheng, M. P., Vinh, D. C., Boutet, P., Roman, F., Van Der Most, R., Ceregido, M. A., Dionne, M., Tellier, G., Gauthier, J.-S., Essink, B., Libman, M., Haffizulla, J., Fréchette, A., D'Aoust, M.-A., Landry, N. & Ward, B. J. (2022). Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities. NPJ vaccines, vol. 7, p. 142.
  6. Schwartz, I. S., Lee, T. C., McDonald, E. G. & Laupland, K. B. (2021). What went wrong: A reckoning of Canada's contributions to evidence-based medicine through clinical trials during the COVID-19 pandemic. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 6, p. 241-244.
  7. Li, J., Frenette, C. & Loo, V. G. (2022). Diagnostic yield of serial SARS-CoV-2 testing in hospitalized patients. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 181-185.
  8. Barkati, S. & Harrison, L. B. (2022). Monkeypox outbreak 2022: "See one, do one, teach one" no longer the rule. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 157-158.
  9. Mendel, A., Colmegna, I., Bourque, G., Rajda, E., Lee, T. C., Gálvez, J. H., Vinet, É. & Cheng, M. P. (2022). More than a 'Hundred Days War': Persistent SARS-CoV-2 infection in a patient with ANCA-associated vasculitis. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 7, p. 131-134.
  10. Domínguez-Gil, B., Ascher, N. L., Fadhil, R. A. S., Muller, E., Cantarovich, M., Ahn, C., Berenguer, M., Bušić, M., Egawa, H., Gondolesi, G. E., Haberal, M., Harris, D., Hirose, R., Ilbawi, A., Jha, V., López-Fraga, M., Andrés Madera, S., Najafizadeh, K., O'Connell, P. J., Rahmel, A., Shaheen, F. A. M., Twahir, A., Van Assche, K., Wang, H., Haraldsson, B., Chatzixiros, E. & Delmonico, F. L. (2022). The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation. Transplantation, vol. 106, p. 2111-2117.
  11. Carazo, S., Skowronski, D. M., Brisson, M., Sauvageau, C., Brousseau, N., Gilca, R., Ouakki, M., Barkati, S., Fafard, J., Talbot, D., Gilca, V., Deceuninck, G., Garenc, C., Carignan, A., De Wals, P. & De Serres, G. (2022). Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada. JAMA network open, vol. 5, p. e2236670.
  12. Ouchene, L., Muntyanu, A., Assayag, D., Veilleux, E., Abril, A., Ferrara, G., Yacyshyn, E., Pineau, C. A., O'Brien, E., Baron, M., Osman, M., Gniadecki, R. & Netchiporouk, E. (2022). Skin disorders and interstitial lung disease: Part II. The spectrum of cutaneous diseases with lung disease association. Journal of the American Academy of Dermatology.
  13. Angelo, K. M., Smith, T., Camprubí-Ferrer, D., Balerdi-Sarasola, L., Díaz Menéndez, M., Servera-Negre, G., Barkati, S., Duvignaud, A., Huber, K. L. B., Chakravarti, A., Bottieau, E., Greenaway, C., Grobusch, M. P., Mendes Pedro, D., Asgeirsson, H., Popescu, C. P., Martin, C., Licitra, C., de Frey, A., Schwartz, E., Beadsworth, M., Lloveras, S., Larsen, C. S., Guagliardo, S. A. J., Whitehill, F., Huits, R., Hamer, D. H., Kozarsky, P., Libman, M. & GeoSentinel Network Collaborators (2022). Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. The Lancet. Infectious diseases.
  14. Lee, T. C. & McDonald, E. G. (2022). 'Remdesivir for the treatment of COVID-19' - Author's reply. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  15. Lau, V. I., Fowler, R., Pinto, R., Tremblay, A., Borgia, S., Carrier, F. M., Cheng, M. P., Conly, J., Costiniuk, C. T., Daley, P., Duan, E., Durand, M., Fontela, P. S., Farjou, G., Fralick, M., Geagea, A., Grant, J., Keynan, Y., Khwaja, K., Lee, N., Lee, T. C., Lim, R., O'Neil, C. R., Papenburg, J., Semret, M., Silverman, M., Sligl, W., Somayaji, R., Tan, D. H. S., Tsang, J. L. Y., Weatherald, J., Yansouni, C. P., Zarychanski, R., Murthy, S. & E-CATCO authors, AMMI Clinical Research Network and Canadian Critical Care Trials Group (2022). Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial. CMAJ open, vol. 10, p. E807-E817.
  16. Heron, V., Li Fraine, S., Panaccione, N., Restellini, S., Germain, P., Candido, K., Bernstein, C. N., Bessissow, T., Bitton, A., Chauhan, U. K., Lakatos, P. L., Marshall, J. K., Michetti, P., Seow, C. H., Rosenfeld, G., Panaccione, R. & Afif, W. (2022). Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of Response. Journal of the Canadian Association of Gastroenterology, vol. 5, p. 208-213.
  17. Bessissow, T., Nguyen, G. C., Tarabain, O., Peyrin-Biroulet, L., Foucault, N., McHugh, K. & Ruel, J. (2022). Impact of adalimumab on disease burden in moderate-to-severe ulcerative colitis patients: The one-year, real-world UCanADA study. World journal of gastroenterology, vol. 28, p. 5058-5075.
  18. Ramji, A., Doucette, K., Cooper, C., Minuk, G. Y., Ma, M., Wong, A., Wong, D., Tam, E., Conway, B., Truong, D., Wong, P., Barrett, L., Ko, H. H., Haylock-Jacobs, S., Patel, N., Kaplan, G. G., Fung, S. & Coffin, C. S. (2022). Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue. World journal of gastroenterology, vol. 28, p. 4390-4398.
  19. Hahn, G. D., LeBlanc, J.-F., Golovics, P. A., Wetwittayakhlang, P., Qatomah, A., Wang, A., Boodaghians, L., Liu Chen Kiow, J., Al Ali, M., Wild, G., Afif, W., Bitton, A., Lakatos, P. L. & Bessissow, T. (2022). Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study. World journal of gastroenterology, vol. 28, p. 4823-4833.
  20. Karaky, M., Boucher, G., Mola, S., Foisy, S., Beauchamp, C., Rivard, M.-E., Burnette, M., Gosselin, H., iGenoMed Consortium, Bitton, A., Charron, G., Goyette, P. & Rioux, J. D. (2022). Prostaglandins and calprotectin are genetically and functionally linked to the Inflammatory Bowel Diseases. PLoS genetics, vol. 18, p. e1010189.
  21. Carazo, S., Skowronski, D. M., Brisson, M., Barkati, S., Sauvageau, C., Brousseau, N., Gilca, R., Fafard, J., Talbot, D., Ouakki, M., Gilca, V., Carignan, A., Deceuninck, G., De Wals, P. & De Serres, G. (2022). Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study. The Lancet. Infectious diseases.
  22. Kurti, Z., Gonczi, L., Lakatos, L., Golovics, P., Pandur, T., David, G., Erdelyi, Z., Szita, I. & Lakatos, P. L. (2022). Epidemiology, treatment strategy, natural disease course and surgical outcomes of patients with ulcerative colitis in Western Hungary - a population-based study between 2007 and 2018, data from the Veszprem County cohort. Journal of Crohn's & colitis.
  23. McDonald, E. G., Prosty, C., Hanula, R., Bortolussi-Courval NClin, É., Albuquerque, A., Tong, S. Y. C., Hamilton, F., Lee, T. C., McDonald, E. G., Prosty, C., Hanula, R., Bortolussi-Courval NClin, É., Albuquerque, A., Tong, S. Y. C., Hamilton, F. & Lee, T. C. (2022). Observational vs. Randomized Controlled Trials to Inform Antibiotic Treatment Durations:A Narrative Review. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  24. Caya, C., Maheu-Giroux, M., Xia, Y., Serhir, B., Morin, V., Libman, M., Corsini, R., Goldfarb, D. M., Wong, T., Singh, A. E. & Yansouni, C. P. (2022). Stopping syphilis transmission in Arctic communities through rapid diagnostic testing: The STAR study protocol. PloS one, vol. 17, p. e0273713.
  25. Gonczi, L., Lakatos, L., Kurti, Z., Golovics, P., Pandur, T., David, G., Erdelyi, Z., Szita, I. & Lakatos, P. L. (2022). Incidence, prevalence, disease course and treatment strategy of Crohn's disease patients from the Veszprem cohort, Western Hungary - a population-based inception cohort study between 2007 and 2018. Journal of Crohn's & colitis.

 

Campus de l'Université McGill

  1. D'Iorio, M. & Dewar, K. (2023). Replication-associated inversions are the dominant form of bacterial chromosome structural variation. Life science alliance, vol. 6.
  2. Xu, Z., Choi, J.-H., Dai, D. L., Luo, J., Ladak, R. J., Li, Q., Wang, Y., Zhang, C., Wiebe, S., Liu, A. C. H., Ran, X., Yang, J., Naeli, P., Garzia, A., Zhou, L., Mahmood, N., Deng, Q., Elaish, M., Lin, R., Mahal, L. K., Hobman, T. C., Pelletier, J., Alain, T., Vidal, S. M., Duchaine, T., Mazhab-Jafari, M. T., Mao, X., Jafarnejad, S. M. & Sonenberg, N. (2022). SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translation. Proceedings of the National Academy of Sciences of the United States of America, vol. 119, p. e2204539119.
  3. Markarian, N. M., Galli, G., Patel, D., Hemmings, M., Nagpal, P., Berghuis, A. M., Abrahamyan, L. & Vidal, S. M. (2022). Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency. Frontiers in microbiology, vol. 13, p. 933983.
  4. Béliveau, C., Gagné, P., Picq, S., Vernygora, O., Keeling, C. I., Pinkney, K., Doucet, D., Wen, F., Johnston, J. S., Maaroufi, H., Boyle, B., Laroche, J., Dewar, K., Juretic, N., Blackburn, G., Nisole, A., Brunet, B., Brandao, M., Lumley, L., Duan, J., Quan, G., Lucarotti, C. J., Roe, A. D., Sperling, F. A. H., Levesque, R. C. & Cusson, M. (2022). The Spruce Budworm Genome: Reconstructing the Evolutionary History of Antifreeze Proteins. Genome biology and evolution.
  5. Mindt, B. C., Krisna, S. S., Duerr, C. U., Mancini, M., Richer, L., Vidal, S. M., Gerondakis, S., Langlais, D. & Fritz, J. H. (2021). The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation. Frontiers in immunology, vol. 12, p. 664218.
  6. Abed, J. Y., Déraspe, M., Bérubé, È., D'Iorio, M., Dewar, K., Boissinot, M., Corbeil, J., Bergeron, M. G. & Roy, P. H. (2021). Complete Genome Sequences of Klebsiella michiganensis and Citrobacter farmeri, KPC-2-Producers Serially Isolated from a Single Patient. Antibiotics (Basel, Switzerland), vol. 10.
  7. Mancini, M., Charbonneau, B., Langlais, D. & Vidal, S. M. (2021). The c-Rel transcription factor limits early interferon and neuroinflammatory responses to prevent herpes simplex encephalitis onset in mice. Scientific reports, vol. 11, p. 21171.
  8. Cavestri, C., Savard, P., Fliss, I., Emond-Rhéault, J.-G., Hamel, J., Kukavica-Ibrulj, I., Boyle, B., Daigle, F., Malo, D., Bekal, S., Harris, L. J., Levesque, R. C., Goodridge, L. & LaPointe, G. (2022). Salmonella enterica subsp. enterica virulence potential can be linked to higher survival within a dynamic in vitro human gastrointestinal model. Food microbiology, vol. 101, p. 103877.
  9. Charlier, J., Nadon, R. & Makarenkov, V. (2021). Accurate deep learning off-target prediction with novel sgRNA-DNA sequence encoding in CRISPR-Cas9 gene editing. Bioinformatics (Oxford, England).
  10. Xu, G., van Bruggen, R., Gualtieri, C. O., Moradin, N., Fois, A., Vallerand, D., De Sa Tavares Russo, M., Bassenden, A., Lu, W., Tam, M., Lesage, S., Girouard, H., Avizonis, D. Z., Deblois, G., Prchal, J. T., Stevenson, M., Berghuis, A., Muir, T., Rabinowitz, J., Vidal, S. M., Fodil, N. & Gros, P. (2020). Bisphosphoglycerate Mutase Deficiency Protects against Cerebral Malaria and Severe Malaria-Induced Anemia. Cell reports, vol. 32, p. 108170.
  11. Emond-Rheault, J.-G., Hamel, J., Jeukens, J., Freschi, L., Kukavica-Ibrulj, I., Boyle, B., Tamber, S., Malo, D., Franz, E., Burnett, E., Daigle, F., Arya, G., Sanderson, K., Wiedmann, M., Slawson, R. M., Weadge, J. T., Stephan, R., Bekal, S., Gruenheid, S., Goodridge, L. D. & Levesque, R. C. (2020). The Salmonella enterica Plasmidome as a Reservoir of Antibiotic Resistance. Microorganisms, vol. 8.
  12. Cavalcanti, G. S., Wasserscheid, J., Dewar, K. & Shikuma, N. J. (2020). Complete Genome Sequences of Two Marine Biofilm Isolates, Leisingera sp. nov. Strains 201A and 204H, Novel Representatives of the Roseobacter Group. Microbiology resource announcements, vol. 9.
  13. Crouse, A., Schramm, C., Emond-Rheault, J.-G., Herod, A., Kerhoas, M., Rohde, J., Gruenheid, S., Kukavica-Ibrulj, I., Boyle, B., Greenwood, C. M. T., Goodridge, L. D., Garduno, R., Levesque, R. C., Malo, D. & Daigle, F. (2020). Combining Whole-Genome Sequencing and Multimodel Phenotyping To Identify Genetic Predictors of Salmonella Virulence. mSphere, vol. 5.
  14. Mancini, M. & Vidal, S. M. (2020). Mechanisms of Natural Killer Cell Evasion Through Viral Adaptation. Annual review of immunology, vol. 38, p. 511-539.
  15. Bayega, A., Djambazian, H., Tsoumani, K. T., Gregoriou, M.-E., Sagri, E., Drosopoulou, E., Mavragani-Tsipidou, P., Giorda, K., Tsiamis, G., Bourtzis, K., Oikonomopoulos, S., Dewar, K., Church, D. M., Papanicolaou, A., Mathiopoulos, K. D. & Ragoussis, J. (2020). De novo assembly of the olive fruit fly (Bactrocera oleae) genome with linked-reads and long-read technologies minimizes gaps and provides exceptional Y chromosome assembly. BMC genomics, vol. 21, p. 259.
  16. Péan, N., Le Lay, A., Brial, F., Wasserscheid, J., Rouch, C., Vincent, M., Myridakis, A., Hedjazi, L., Dumas, M.-E., Grundberg, E., Lathrop, M., Magnan, C., Dewar, K. & Gauguier, D. (2020). Dominant gut Prevotella copri in gastrectomised non-obese diabetic Goto-Kakizaki rats improves glucose homeostasis through enhanced FXR signalling. Diabetologia, vol. 63, p. 1223-1235.
  17. Kennedy, J. M., Georges, A., Bassenden, A. V., Vidal, S. M., Berghuis, A. M., Taniuchi, I., Majewski, J., Lathrop, M., Behr, M. A., Langlais, D. & Gros, P. (2020). ZBTB7B (ThPOK) Is Required for Pathogenesis of Cerebral Malaria and Protection against Pulmonary Tuberculosis. Infection and immunity, vol. 88.
  18. Hebert, F. O., Freschi, L., Blackburn, G., Béliveau, C., Dewar, K., Boyle, B., Gundersen-Rindal, D. E., Sparks, M. E., Cusson, M., Hamelin, R. C. & Levesque, R. C. (2019). Expansion of LINEs and species-specific DNA repeats drives genome expansion in Asian Gypsy Moths. Scientific reports, vol. 9, p. 16413.
  19. Zhang, J., Teh, M., Kim, J., Eva, M. M., Cayrol, R., Meade, R., Nijnik, A., Montagutelli, X., Malo, D. & Jaubert, J. (2019). A Loss-of-Function Mutation in the Integrin Alpha L (Itgal) Gene Contributes to Susceptibility to Salmonella enterica Serovar Typhimurium Infection in Collaborative Cross Strain CC042. Infection and immunity, vol. 88.
  20. Chehboun, S., Leiva-Torres, G. A., Charbonneau, B., Eveleigh, R., Bourque, G. & Vidal, S. M. (2020). A point mutation in the linker domain of mouse STAT5A is associated with impaired NK-cell regulation. Genes and immunity, vol. 21, p. 136-141.
  21. Desloges, I., Taylor, J. A., Leclerc, J.-M., Brannon, J. R., Portt, A., Spencer, J. D., Dewar, K., Marczynski, G. T., Manges, A., Gruenheid, S., Le Moual, H. & Thomassin, J.-L. (2019). Identification and characterization of OmpT-like proteases in uropathogenic Escherichia coli clinical isolates. MicrobiologyOpen, vol. 8, p. e915.
  22. Yarborough, M., Nadon, R. & Karlin, D. G. (2019). Four erroneous beliefs thwarting more trustworthy research. eLife, vol. 8.
  23. Yuki, K. E., Marei, H., Fiskin, E., Eva, M. M., Gopal, A. A., Schwartzentruber, J. A., Majewski, J., Cellier, M., Mandl, J. N., Vidal, S. M., Malo, D. & Dikic, I. (2019). CYRI/FAM49B negatively regulates RAC1-driven cytoskeletal remodelling and protects against bacterial infection. Nature microbiology, vol. 4, p. 1516-1531.
  24. Minerbi, A., Gonzalez, E., Brereton, N. J. B., Anjarkouchian, A., Dewar, K., Fitzcharles, M.-A., Chevalier, S. & Shir, Y. (2019). Altered microbiome composition in individuals with fibromyalgia. Pain, vol. 160, p. 2589-2602.
  25. Železnjak, J., Lisnić, V. J., Popović, B., Lisnić, B., Babić, M., Halenius, A., L'Hernault, A., Roviš, T. L., Hengel, H., Erhard, F., Redwood, A. J., Vidal, S. M., Dölken, L., Krmpotić, A. & Jonjić, S. (2019). The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors. The Journal of experimental medicine, vol. 216, p. 1809-1827.